Health news and commentary gathered by MedPage Today staff ...

A glucagon and GLP-1 receptor dual agonist showed promise for reducing liver fat in a phase II study of patients with metabolic dysfunction-associated steatotic liver disease and steatohepatitis. ( ...

The FDA approved zidesamtinib (Jideytro) for previously treated adults with locally advanced or metastatic ROS1-positive ...

Emerging evidence has suggested GLP-1 drug use may be associated with hair loss. A target trial emulation of adults with ...

Defense Secretary Pete Hegseth's new initiative to test and treat troops for low testosterone has prompted a federal judge to question the differences between that kind of testosterone replacement ...

Previous research suggested that women who had abortions had higher rates of suicide attempts and antidepressant use, but ...

The Trump administration is withholding a combined total of more than $1 billion in Medicaid funds from California and ...

Jury selection began Monday in the trial of a Massachusetts mother who strangled her three children while undergoing medical ...

Reproductive health should be addressed from the time of diagnosis of cystic fibrosis and annually thereafter, with a more ...

Higher levels of disinfection byproducts in drinking water were linked to a higher risk of uterine cancer among a cohort of ...

President Donald Trump said that generic drugs imported into the U.S. will face a 100% levy starting in August 2028, which ...

Five major pregnancy complications were independently associated with heightened long-term risk of peripheral artery disease ...